| 1 |
34223109 | CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales. | 2021 Jun |
2 |
| 2 |
24261683 | Molecular dynamics and molecular docking studies on E166A point mutant, R274N/R276N double mutant, and E166A/R274N/R276N triple mutant forms of class A β-lactamases. | 2014 Dec |
1 |
| 3 |
25008823 | Erythromycin-resistant genes in group A β-haemolytic Streptococci in Chengdu, Southwestern China. | 2014 Jul-Sep |
1 |
| 4 |
19285734 | Rate of eradication of group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir. | 2009 May |
1 |
| 5 |
20041005 | Comparative Study of 5-Day and 10-Day Cefditoren Pivoxil Treatments for Recurrent Group A beta-Hemolytic Streptococcus pharyngitis in Children. | 2009 |
1 |
| 6 |
11001127 | Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies. | 2000 Sep |
1 |
| 7 |
3906584 | Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life. | 1985 Sep-Oct |
1 |
| 8 |
6286266 | [Antibiotic treatment of human actinomykoses (author's transl)]. | 1982 Aug 27 |
1 |
| 9 |
6269426 | Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms. | 1981 Sep |
1 |